Genital Diseases, Female  >>  Proleukin (aldesleukin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
NCT00019084: Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer

Completed
2
US
aldesleukin, mutant p53 peptide pulsed dendritic cell vaccine, ras peptide cancer vaccine, sargramostim, therapeutic autologous lymphocytes, therapeutic tumor infiltrating lymphocytes
National Cancer Institute (NCI)
Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer
 
05/03
NCT00019331: Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Completed
2
US
aldesleukin, ras peptide cancer vaccine, sargramostim, DetoxPC
National Cancer Institute (NCI)
Colorectal Cancer, Endometrial Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Melanoma (Skin), Pancreatic Cancer, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific
 
05/07
NCT00001827: p53 Vaccine for Ovarian Cancer

Terminated
2
21
US
aldesleukin, incomplete Freund's adjuvant, p53 peptide vaccine, sargramostim, therapeutic autologous dendritic cells, in vitro-treated peripheral blood stem cell transplantation
National Cancer Institute (NCI)
Ovarian Neoplasm
12/07
01/13
APOLLO, NCT00652899: Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

Terminated
2
14
US
Allopurinol, Zyloprim, Cyclophosphamide, Cytoxan, Fludarabine phosphate, Fludarabine, total-body irradiation, TBI, Allogeneic natural killer cells, related donor haploidentical allogenic cell infusion, Aldesleukin, IL-2, Interleukin-2
Masonic Cancer Center, University of Minnesota
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
08/09
08/09
NCT01585428: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Completed
2
29
US
Fludarabine, Fludara, Cyclophosphamide, Cytoxan, Young TIL, TIL, Aldesleukin, Proleukin
National Cancer Institute (NCI)
Cervical Cancer, Oropharyngeal Cancer, Vaginal Cancer, Anal Cancer, Penile Cancer
04/16
08/16
NCT00019916: Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer

Completed
1/2
US
aldesleukin, p53 peptide vaccine, in vitro-treated peripheral blood stem cell transplantation
National Cancer Institute (NCI)
Breast Cancer, Ovarian Cancer
 
07/06
NCT02280811: T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Completed
1/2
12
US
Fludarabine, Fludara, Cyclophosphamide, Cytoxan, E6 TCR, Aldesleukin, IL-2
National Cancer Institute (NCI)
Vaginal Cancer, Cervical Cancer, Anal Cancer, Penile Cancer, Oropharyngeal Cancer
06/16
06/16

Download Options